#162FUZKK selection 101–300

ADC Therapeutics

Switzerland · Switzerland

Oncology / ADC / high-potencyFinished dosage forms and small molecules

Manufacturing profile

Country
Switzerland
Regulatory region
Switzerland
ISO
CHE

Selection basis

The company is placed in positions 101–300 as a manufacturer, biotechnology company, generics player or CDMO with practical relevance to the FUZKK utility catalog.

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. The mapping does not claim actual use of FUZKK, a specific installed equipment model or a product not confirmed by the public company profile.

Representative manufacturing and QC chain

  1. 1Contained dispensing and high-potency handling
  2. 2Chemical synthesis or biologic upstream
  3. 3Purification and formulation
  4. 4HPLC/LC-MS/CE and potency analytics
  5. 5Controlled fill-finish, cleaning and release evidence
  6. 6Raw-material receipt and identification
  7. 7Dispensing, blending and granulation
  8. 8Tableting, encapsulation or solution preparation
  9. 9Packaging and labelling

Relevant FUZKK packages

Lumex — instrumental QC

Suggested first pilot

  1. Confirm one real product, method or recurring QC review.
  2. Record the instrument, export format and current specification.
  3. Select 3–7 utilities from the map above.
  4. Run a PASS/FAIL sample and agree the expected output.
  5. After user validation, expand to other products and sites.

Mapping boundary

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. The mapping does not claim actual use of FUZKK, a specific installed equipment model or a product not confirmed by the public company profile.

Methodology